Trial Profile
Phase II Trial of Weekly Docetaxel and Four Weekly Carboplatin Combination in the First-Line Treatment of Advanced Non-Small Cell Lung Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Aug 2010
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Docetaxel (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms Carbo-Tax
- Sponsors Sanofi
- 12 Jan 2010 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.
- 12 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Jan 2009 New trial record.